We are excited to announce that SMSbiotech will participate in the upcoming Drug Discovery Strategic Summit in Boston on May 4th. Leaders from various industries will converge to discuss the latest advancements in drug discovery.
Dr. Rahmo, our Chief Scientific Officer, will be attending as a panelist to share our expertise in targeted therapies for age-related diseases such as COPD and other diseases. At SMSbiotech, we recognize the significant economic impact of age-related diseases. According to a report by the American Lung Association, COPD alone costs the US economy about $36 billion annually. The Centers for Disease Control and Prevention (CDC) estimate that chronic diseases in general, including age-related diseases, accounted for $3.7 trillion in healthcare spending in the United States in 2019.
We are proud to be at the forefront of emerging therapies for these devastating diseases. Our targeted therapies are designed to address the root causes of these conditions and bring about lasting change. We are excited to connect with our colleagues and explore the latest developments in this rapidly evolving field. Our participation in this summit will help us serve different indications and foster collaborations and progress in the fight against these devastating diseases.
Please feel free to contact us for more information.
